Valeant Pharmaceuticals International acquires Private Formula International HoldingsSeptember 30th, 2009 Valeant Pharmaceuticals buys Private Formula Int.ALISO VIEJO, Calif. — Valeant Pharmaceuticals International said Wednesday it will buy Private Formula International Holdings Pty Ltd., a skin care company, to boost its dermatology portfolio.
Judge denies temporary restraining order Wyeth sought to block rival's generic antibioticSeptember 24th, 2009 Wyeth denied order to block rival's generic drugTRENTON, N.J. — A federal judge on Thursday rejected drugmaker Wyeth's request for a temporary restraining order to block a rival from selling a generic version of a lucrative Wyeth antibiotic.
KV Pharmaceutical sells proposed generic acne treatment to Perrigo for more than $14 millionSeptember 21st, 2009 KV sells generic drug application to PerrigoST. LOUIS. — KV Pharmaceutical Co.
Moody's assigned 'Ba1' rating to Watson Pharma sale of $850M in senior unsecured notesAugust 18th, 2009 Moody's rates Watson note offering as 'junk'NEW YORK — Moody's Investors Service on Tuesday assigned a "junk" rating to Watson Pharmaceuticals Inc.'s $850 million offering of senior notes. Moody's gave a Ba1 rating to the sale of five- and 10-year notes.
Watson Pharmaceuticals offering $850 million in mix of senior notesAugust 18th, 2009 Watson offering $850 million in notesMORRISTOWN, N.J. — Drug developer Watson Pharmaceuticals Inc.
King Pharmaceuticals says 2nd quarter profit falls, but performance tops expectationsAugust 6th, 2009 King Pharmaceuticals reports 2Q profit dropBRISTOL, Tenn. — Drug developer King Pharmaceuticals said Thursday its second-quarter profit dropped, as generic competition continued to hurt drug sales.
Watson Pharmaceuticals' CFO takes leave of absence, health reasons citedJuly 27th, 2009 Watson Pharmaceuticals' CFO takes leaveMORRISTOWN, N.J. — Watson Pharmaceuticals Inc.
Report: P&G discussions on selling pharmaceutical business advancingJuly 22nd, 2009 P&G drug-business sale talks advance, reports sayCINCINNATI — Talks on a sale of Procter & Gamble Co.'s pharmaceutical business are reportedly advancing. The Wall Street Journal in Wednesday's editions cited unidentified people familiar with the matter who say several potential buyers include specialty drug maker Warner Chilcott Ltd., and private-equity firm Cerberus Capital Management LP, and that a possible sale price is some $3 billion.
Federal agents contact maker of drug in Jackson probe; company recalls batches of propofolJuly 14th, 2009 Batch of drug central to Jackson probe recalledLOS ANGELES — Federal drug enforcement officials have contacted the maker of the powerful anesthetic propofol (PRO-puh-fall) as part of their investigation into Michael Jackson's death. A spokeswoman for Teva Pharmaceuticals says the Drug Enforcement Administration asked the company about a specific batch of the drug.
Closing arguments end in Ala. lawsuit accusing drug company of overcharging Medicaid programsJuly 8th, 2009 Closing arguments end in Ala. drug pricing lawsuitMONTGOMERY, Ala.
EU warns of antitrust probes into major drug makers for stalling cheaper generic versionsJuly 8th, 2009 EU warns of antitrust probes into drug makersBRUSSELS — The European Union is warning of a wave of antitrust probes into major drug makers Wednesday, saying they were deliberately stalling cheaper generic medicines. It started an investigation Wednesday into France's Les Laboratoires Servier for hindering the launch of generic versions of its heart disease drug.
Roche discontinues sales of acne drug Accutane amid tough generic competitionJune 26th, 2009 Roche discontinues sales of acne drug AccutaneNEW YORK — Roche said Friday it will stop selling the acne drug Accutane as sales of the treatment continue falling amid competition from less expensive generic versions. Generic versions of the acne treatment have been on the market since 2002 and Roche's branded product's market share has since slipped to less than 5 percent.
Swiss drug maker Roche donates over 5M packs of anti-viral Tamiflu to UN health agencyMay 12th, 2009 Roche donates over 5M packs of anti-viral to WHOBASEL, Switzerland — Swiss pharmaceuticals company Roche Holding AG said Tuesday it is donating 5.65 million packets of Tamiflu, one of two anti-viral drugs known to be effective against swine flu, to the World Health Organization. Roche said 5 million packets will be used to replenish stockpiles that were depleted when WHO sent previously donated supplies to poor countries after the appearance of a new type of swine flu, dubbed A(H1N1).
Ranbaxy posts Rs.1,045 crore net loss in 2008March 30th, 2009 MUMBAI - Leading drug maker Ranbaxy Laboratories Monday reported a net loss of Rs.1,044.8 crore ($204 million) for 2008 as against a net profit of Rs.617.7 crore in the previous year. However, the company's total income went up 9.85 percent to Rs.4,681.7 crore in 2008 from Rs.4,261.9 crore in 2007.
Dr. Reddy's net rises 10 percentJanuary 19th, 2009 MUMBAI - Leading drug manufacturer, Dr. Reddy's Laboratories, Tuesday announced its net profits were up 10 percent to reach Rs.1.9 billion in the third quarter this fiscal.
Loading ...